
XVIVO PERFUSION
A Brand Platform for Life-Saving Technology

Objective
XVIVO pioneers machine perfusion technology, transforming the way organ transplants are preserved and performed. Their mission is clear: to support transplant teams with cutting-edge solutions that improve patient survival rates worldwide.
As their portfolio grew, so too did the number of stories it told. Each product had its own technical narrative, and the corporate brand needed to hold them together with one platform. Better cohesion was required, as this would follow XVIVO onto the global congress circuit, where the leading names in medical technology compete for the attention of clinicians.
XVIVO needed a platform that could express every product clearly and consistently, all while preserving and articulating the scientific detail clinicians rely on – to give the brand an eye-catching presence and to stand out on the exhibition floor with its credibility intact.
connecting the brand to every product.
compared to previous years.
designed for repeat use across congresses.
How we did it
We worked from the top down, then the bottom up, then out – into the real world where it would be utilised.
We started with an objective assessment of XVIVO’s corporate brand: what was working and how well it carried across the portfolio. That gave us a clear view of what to keep and where the brand needed to work harder.
The purpose went to the heart of why XVIVO exists: “We believe in an extended life of organs. Nobody should die waiting for a new organ.” A clear position (new standards in life-extending technologies for organs), an offer (enabling the world’s leading clinicians and scientists to extend horizons in transplantation) and four values (customer centric, collaborative, purposeful and research driven) completed the platform. All of it is distilled into one brand strapline: “Extending horizons in organ transplantation.”
A product framework mapped each technology against the same questions: what it is, what it does, why it matters and how it serves the purpose through preservation, evaluation or transportation. That simplified complex science into clear value and gave every product a marketing proposition built around a shared idea of power, from “Unlock the power of oxygen” for Kidney Assist Transport to “Realise the power of potential” for XPS™ and STEEN Solution™ and “Extend the power of time” for the XVIVO Heart Device.
A technology strapline, “The power to save organs, so others can save lives”, links every product back to the corporate brand.
With the strategy set, we developed a bold, refined brand expression that balances scientific authority with emotional impact. The visual and messaging system speaks to clinicians with the precision they expect, while keeping the human stakes of transplantation in plain view: the patients waiting for an organ, and the teams working to give them one.
Brand guidelines codify the system, giving XVIVO’s teams and partners the rules and assets to apply it consistently wherever the brand appears. The platform extends into XVIVO’s website and digital communications, so the story clinicians find online matches the one they hear in person.
The global congress circuit is where the brand is really tested. Medical exhibitions are crowded and often consist of brief interactions, and XVIVO needed to hold attention without diluting its scientific credibility. We designed an exhibition strategy that gives the brand a consistent, adaptable presence across multiple congresses, bringing the brand story and product propositions together with the human stakes of transplantation in one space.
At its core is a modular system of owned, reusable brand assets that adapts to different stand sizes and layouts. It removes the need to redesign for every event, which speeds up production and improves cost-effectiveness, while supporting XVIVO’s own sustainability goals.
The work shows how a clear brand platform can turn technical depth into value that resonates in a regulated and evidence-led sector, with communications that are credible to clinicians and meaningful to the patients their technology serves.







